Simulations Plus (NASDAQ:SLP) Lowered to “Hold” Rating by Wall Street Zen

Wall Street Zen lowered shares of Simulations Plus (NASDAQ:SLP) from a buy rating to a hold rating in a research note issued to investors on Saturday morning.

SLP has been the topic of several other research reports. Zacks Research lowered Simulations Plus from a “strong-buy” rating to a “hold” rating in a report on Monday, February 2nd. BTIG Research lowered shares of Simulations Plus from a “buy” rating to a “neutral” rating in a report on Thursday, December 18th. TD Cowen restated a “hold” rating on shares of Simulations Plus in a research report on Thursday, January 8th. Finally, Citigroup reaffirmed a “market perform” rating on shares of Simulations Plus in a research note on Tuesday, January 6th. Three research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Simulations Plus currently has a consensus rating of “Hold” and an average target price of $25.00.

Simulations Plus Price Performance

SLP stock opened at $11.99 on Friday. Simulations Plus has a 1 year low of $11.09 and a 1 year high of $36.45. The firm has a market capitalization of $241.60 million, a PE ratio of -3.75 and a beta of 1.19. The business has a 50 day simple moving average of $13.06 and a 200-day simple moving average of $16.06.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings data on Thursday, January 8th. The technology company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.05). The company had revenue of $18.42 million for the quarter, compared to analyst estimates of $18.05 million. Simulations Plus had a positive return on equity of 14.02% and a negative net margin of 81.66%.During the same period last year, the firm posted $0.17 EPS. On average, equities research analysts expect that Simulations Plus will post 1.09 EPS for the current year.

Hedge Funds Weigh In On Simulations Plus

Several large investors have recently modified their holdings of SLP. Royal Bank of Canada increased its position in shares of Simulations Plus by 26.6% during the 1st quarter. Royal Bank of Canada now owns 114,885 shares of the technology company’s stock worth $2,817,000 after purchasing an additional 24,132 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Simulations Plus by 4.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock valued at $233,000 after buying an additional 390 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in Simulations Plus during the first quarter worth about $255,000. Woodline Partners LP increased its position in shares of Simulations Plus by 32.1% during the first quarter. Woodline Partners LP now owns 13,239 shares of the technology company’s stock valued at $325,000 after acquiring an additional 3,220 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Simulations Plus by 3.1% during the second quarter. Geode Capital Management LLC now owns 397,851 shares of the technology company’s stock valued at $6,943,000 after acquiring an additional 12,003 shares during the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.